The New Jersey Supreme Court has reinstated a $25.16 million judgment in favor of an Alabama man who claims he contracted Crohn’s disease after taking Accutane, an acne drug that has been the subject of mass tort litigation in the state for more than a decade.
In a unanimous ruling, the court said the verdict in favor of plaintiff Andrew McCarrell should stand, even though his lawsuit was filed after the statute of limitations in his home state had expired.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
